2025

• Rahman, M., David, M., Steinberg, J., Cust, A., Yu, X., Rutherford, C., Banks, E., Byles, J., Canfell, K. (2025). Association of optimism and social support with health-related quality of life among Australian women cancer survivors - A cohort study. Asia-Pacific Journal of Clinical Oncology, 21(2), 221-231. [More Information]

2024

• Milley, K., Rankin, N., Yates, P., Emery, J., Druce, P., McNamara, M., Bergin, R., Chan, R., Cust, A., Davis, N., et al (2024). Cancer in general practice research priorities in Australia. Australian Journal of General Practice, 53(4), 227-234. [More Information]
• Pham, J., Allen, N., Star, P., Cust, A., Guitera, P., Marghoob, A., Paoli, J., Zaludek, I., Smith, A. (2024). Full-body skin examination in screening for cutaneous malignancy: A focus on concealed sites and the practices of international dermatologists. JEADV Clinical Practice. [More Information]
• Martin, A., Cust, A., Lo, S., Morton, R., Kasparian, N., Collgros Totosaus, H., Teh, N., Martin, L., Guitera, P. (2024). Mobile teledermoscopy for patients at high risk of cutaneous melanoma: A single-arm, feasibility study of a clinical intervention at two tertiary centres (MOBILEMEL). Journal of the European Academy of Dermatology and Venereology. [More Information]
• Smith, J., Espinoza, D., Smit, A., Gallo, B., Smith, A., Lo, S., Guitera, P., Martin, L., Cust, A. (2024). Patient demographic characteristics and risk factors associated with sun protection behaviours in specialist melanoma clinics. Australasian Journal of Dermatology. [More Information]
• Ni, Y., Watts, C., Scolyer, R., Madronio, C., Armstrong, B., Morton, R., Menzies, S., Mann, G., Thompson, J., Cust, A., Lo, S. (2024). Prognosis for people with multiple primary melanomas compared with a single primary melanoma. Journal Of The American Academy Of Dermatology, 90(1), 170-174. [More Information]
• Rahman, M., Hayen, A., Olynyk, J., Cust, A., Irving, D., Karki, S. (2024). Regular whole blood donation and gastrointestinal, breast, colorectal and haematological cancer risk among blood donors in Australia. Vox Sanguinis. [More Information]
• Ho, G., Collgros Totosaus, H., Sinz, C., Melhoranse-Gouveia, B., Gallo, B., Chew, C., Ip, K., Koutsis, J., Lo, S., Schwartz-Aldea, R., Ferguson, P., Martin, L., Smith, A., Cust, A., Guitera, P., et al (2024). Remote cutaneous confocal microscopy: A multicentric prospective study evaluating diagnostic accuracy for melanoma and keratinocyte carcinoma in tertiary settings. Journal Of The American Academy Of Dermatology. [More Information]
• Martin, L., Guitera, P., Long, G., Scolyer, R., Cust, A. (2024). Towards evidence-based skin checks. Medical Journal of Australia, 221(8), 407-409. [More Information]

2023

• Gibbs, D., Thomas, N., Kanetsky, P., Luo, L., Busam, K., Cust, A., Anton-Culver, H., Gallagher, R., Zanetti, R., Rosso, S., et al (2023). Association of functional, inherited vitamin D-binding protein variants with melanoma-specific death. JNCI Cancer Spectrum, 7(5). [More Information]
• Goldstein, A., Qin, R., Chu, E., Elder, D., Massi, D., Adams, D., Harms, P., Robles-Espinoza, C., Newton-Bishop, J., Bishop, D., Holland, E., Cust, A., Schmid, H., Mann, G., et al (2023). Association of germline variants in telomere maintenance genes (POT1, TERF2IP, ACD, and TERT) with spitzoid morphology in familial melanoma: A multi-center case series. JAAD International, 11, 43-51. [More Information]
• So, C., Watts, C., Reyes Marcelino, G., Goldsbury, D., McLoughlin, K., Emery, J., Cust, A. (2023). Diagnostic biopsies of suspected skin cancer in general practice from 2010 to 2017 in Victoria, Australia. British Journal of Dermatology, 188(4), 560-561. [More Information]
• Pham, J., Allen, N., Star, P., Cust, A., Stewart, C., Guitera, P., Marghoob, A., Smith, A. (2023). Full-body skin examination in screening for cutaneous malignancy: a focus on concealed sites and the practices of Australian dermatologists. International Journal Of Dermatology, 63(4), 467-473. [More Information]
• Young, M., Yanes, T., Cust, A., Dunlop, K., Limb, S., Newson, A., Purvis, R., Thiyagarajan, L., Scott, R., Verma, K., Steinberg, J., et al (2023). Human Genetics Society of Australasia Position Statement: Use of Polygenic Scores in Clinical Practice and Population Health. Twin Research and Human Genetics. [More Information]
• Orlow, I., Sadeghi, K., Edmiston, S., Kenney, J., Lezcano, C., Wilmott, J., Cust, A., Scolyer, R., Mann, G., Lee, T., Burke, H., Jakrot, V., Shang, P., Ferguson, P., et al (2023). InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma. PloS One, 18(2023-04-04 00:00:00). [More Information]
• Law, C., Cust, A., Smit, A., Trevena, L., Fernandez Penas, P., Nieweg, O., Menzies, A., Wordsworth, S., Morton, R. (2023). Long-term cost-effectiveness of a melanoma prevention program using genomic risk information compared with standard prevention advice in Australia. Genetics in Medicine, 25(12), 100970. [More Information]
• Bhave, P., Wong, J., McInerney-Leo, A., Cust, A., Lawn, C., Janda, M., Mar, V. (2023). Management of cutaneous melanoma in Australia: a narrative review. Medical Journal of Australia, 218(9), 426-431. [More Information]
• Spanos, S., Singh, N., Laginha, B., Arnolda, G., Wilkinson, D., Smith, A., Cust, A., Braithwaite, J., Rapport, F. (2023). Measuring the quality of skin cancer management in primary care: A scoping review. Australasian Journal of Dermatology. [More Information]
• Cust, A., Scolyer, R. (2023). Melanoma In Situ-Getting the Diagnosis and Prognosis Right. JAMA Dermatology, 159(7), 699-701. [More Information]
• Ho, G., Smith, A., Cust, A., Melhoranse-Gouveia, B., Collgros Totosaus, H., Martin, L., Guitera, P. (2023). Reflectance confocal microscopy in Australia: Perspectives on barriers to implementation and uptake. Australasian Journal of Dermatology, 64(1), e109-e111. [More Information]
• Karki, S., Bell, K., Hayen, A., Liu, B., Cust, A., Olynyk, J., Irving, D. (2023). Regular high-frequency whole blood donation and risk of cardiovascular disease in middle-aged and older blood donors in Australia. Transfusion. [More Information]
• Adler, N., Cust, A., Mar, V., Martin, L., Guitera, P. (2023). Reply to: 'Melanoma diagnosis at a specialist dermatology practice without the use of photographic surveillance'. Australasian Journal of Dermatology, 64(3), e307-e308. [More Information]
• Ward, S., Autuori, I., Luo, L., LaPilla, E., Yoo, S., Sharma, A., Busam, K., Olilla, D., Dwyer, T., Anton-Culver, H., Cust, A., et al (2023). Sex-Specific Associations of MDM2 and MDM4 Variants with Risk of Multiple Primary Melanomas and Melanoma Survival in Non-Hispanic Whites. Cancers, 15(10). [More Information]
• Reyes Marcelino, G., McLoughlin, K., Harrison, C., Watts, C., Kang, Y., Aranda, S., Aitken, J., Guitera, P., Cust, A. (2023). Skin cancer-related conditions managed in general practice in Australia, 2000-2016: A nationally representative, cross-sectional survey. BMJ Open, 13(5). [More Information]
• Yan, M., Cust, A., Soyer, H., Janda, M., Loewe, K., Byars, G., Fishburn, P., White, P., Mahumud, R., Saw, R., Fernandez Penas, P., Guitera, P., Morton, R., et al (2023). Study protocol for a randomised controlled trial to evaluate the use of melanoma surveillance photography to the Improve early detection of MelanomA in ultra-hiGh and high-risk patiEnts (the IMAGE trial). Trials, 24(1). [More Information]
• Blake, S., Guitera, P., Cust, A., Galea, C., Lo, S., Scolyer, R., Armstrong, B., Thompson, J., Menzies, S., Madronio, C., Morton, R., Mann, G., Watts, C. (2023). The association of dermatologist demographic density with melanoma survival in New South Wales, Australia. Australasian Journal of Dermatology, 64(3), 425-429. [More Information]
• Wallingford, C., Demeshko, A., Krishnakripa, A., Smit, D., Duffy, D., Betz-Stablein, B., Pflugfelder, A., Jagirdar, K., Holland, E., Mann, G., Cust, A., et al (2023). The MC1R r allele does not increase melanoma risk in MITF E318K carriers. British Journal of Dermatology, 188(6), 770-776. [More Information]
• Zhang, R., Smit, A., Espinoza, D., Allen, M., Reyes Marcelino, G., Kimlin, M., Lo, S., Sharman, A., Law, M., Kanetsky, P., Mann, G., Cust, A. (2023). Validation of self-reported sun exposure against electronic ultraviolet radiation dosimeters. International Journal of Epidemiology, 52(1), 324-328. [More Information]
• Dunlop, K., Rankin, N., Smit, A., Newson, A., Keogh, L., Cust, A. (2023). Views of the Australian public on the delivery of risk-stratified cancer screening in the population: a qualitative study. Public Health Research and Practice, 33(2). [More Information]

2022

• Ackermann, D., Dieng, M., Medcalf, E., Jenkins, M., Van Kemenade, C., Janda, M., Turner, R., Cust, A., Morton, R., Irwig, L., Guitera, P., Hersch, J., Saw, R., Scolyer, R., Drabarek, D., Espinoza, D., Smit, A., Thompson, J., Bell, K., et al (2022). Assessing the Potential for Patient-led Surveillance after Treatment of Localized Melanoma (MEL-SELF): A Pilot Randomized Clinical Trial. JAMA Dermatology, 158(1), 33-42. [More Information]
• Smit, A., Espinoza, D., Fenton, G., Kirk, J., Innes, J., McGovern, M., Limb, S., Turbitt, E., Cust, A. (2022). Communicating Personal Melanoma Polygenic Risk Information: Participants’ Experiences of Genetic Counseling in a Community-Based Study. Journal of Personalized Medicine, 12(10). [More Information]
• Janda, M., Olsen, C., Mar, V., Cust, A. (2022). Early detection of skin cancer in Australia – current approaches and new opportunities. Public Health Research and Practice, 32(1), e3212204. [More Information]
• Lee Solano, M., Robinson, S., Allen, M., Reyes Marcelino, G., Espinoza, D., Beswick, B., Tse, D., Ding, L., Humphreys, L., Van Kemenade, C., Smit, A., Cust, A., et al (2022). Effect of an interactive educational activity using handheld ultraviolet radiation dosimeters on sun protection knowledge among Australian primary school students. Preventive Medicine Reports, 25, 101690-1-101690-5. [More Information]
• Drabarek, D., Habgood, E., Janda, M., Hersch, J., Ackermann, D., Low, D., Low, C., Morton, R., Dieng, M., Cust, A., Morgan, A., Smith, E., Bell, K. (2022). Experiences of Patient-Led Surveillance, Including Patient-Performed Teledermoscopy, in the MEL-SELF Pilot Randomized Controlled Trial: Qualitative Interview Study. JMIR Dermatology, 5(3). [More Information]
• Arnold, M., Singh, D., Laversanne, M., Vignat, J., Vaccarella, S., Meheus, F., Cust, A., De Vries, E., Whiteman, D., Bray, F. (2022). Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040. JAMA Dermatology, 158(5), 495-503. [More Information]
• Steinberg, J., Iles, M., Lee, J., Wang, X., Law, M., Smit, A., Nguyen-Dumont, T., Giles, G., Southey, M., Milne, R., Cust, A., et al (2022). Independent evaluation of melanoma polygenic risk scores in UK and Australian prospective cohorts*. British Journal of Dermatology, 186(5), 823-834. [More Information]
• Luo, L., Shen, R., Arora, A., Orlow, I., Busam, K., Lezcano, C., Lee, T., Hernando, E., Gorlov, I., Amos, C., Cust, A., Wilmott, J., Scolyer, R., et al (2022). Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study. Pigment Cell & Melanoma Research, 35(6), 605-612. [More Information]
• Mercado, G., Newson, A., Espinoza, D., Cust, A., Smit, A. (2022). Motivations and Barriers to Participation in a Randomized Trial on Melanoma Genomic Risk: A Mixed-Methods Analysis. Journal of Personalized Medicine, 12(10). [More Information]
• Drabarek, D., Habgood, E., Ackermann, D., Hersch, J., Janda, M., Morton, R., Guitera, P., Peter Soyer, H., Collgros Totosaus, H., Cust, A., Saw, R., Dieng, M., Bell, K., et al (2022). Perspectives and Experiences of Patient-Led Melanoma Surveillance Using Digital Technologies From Clinicians Involved in the MEL-SELF Pilot Randomized Controlled Trial: Qualitative Interview Study. JMIR Dermatology, 5(4). [More Information]
• Thompson, J., Smith, A., Lo, S., Kasparian, N., Saw, R., Dieng, M., Seaman, L., Martin, L., Guitera, P., Milne, D., Schmid, H., Cust, A., Bartula, I. (2022). Protocol for the implementation of a stepped-care model to address fear of cancer recurrence in patients previously diagnosed with early-stage (0-II) melanoma. BMJ Open, 12(3), e054337-1-e054337-11. [More Information]
• Tan, K., Lo, S., Cust, A., Wolfe, R., Mar, V. (2022). Sensitivity of two Australian melanoma risk tools to identify high-risk individuals among people presenting with their first primary melanoma. Australasian Journal of Dermatology, 63(3), 352-358. [More Information]
• Preston, P., Sinclair, C., Cust, A., Olsen, C. (2022). Skin cancer - time for national leadership to meet critical challenges ahead. Public Health Research and Practice, 32(1), 3212201-1-3212201-4. [More Information]
• Laginha, B., Rapport, F., Smith, A., Wilkinson, D., Cust, A., Braithwaite, J. (2022). Systematic development of quality indicators for skin cancer management in primary care: A mixed-methods study protocol. BMJ Open, 12(6). [More Information]

2021

• Smit, A., Reyes Marcelino, G., Keogh, L., Cust, A., Newson, A. (2021). 'There is a lot of good in knowing, but there is also a lot of downs': Public views on ethical considerations in population genomic screening. Journal of Medical Ethics, 47(12), E28. [More Information]
• Cust, A. (2021). A different finding on whether naevus numbers change during adulthood. British Journal of Dermatology, 184(2), 193. [More Information]
• Dunlop, K., Rankin, N., Smit, A., Salgado, Z., Newson, A., Keogh, L., Cust, A. (2021). Acceptability of risk-stratified population screening across cancer types: Qualitative interviews with the Australian public. Health Expectations, 24(4), 1326-1336. [More Information]
• Vuong, K., Armstrong, B., Espinoza, D., Hopper, J., Aitken, J., Giles, G., Schmid, H., Mann, G., Cust, A., McGeechan, K. (2021). An independent external validation of melanoma risk prediction models using the Australian Melanoma Family Study. British Journal of Dermatology, 184(5), 957-960. [More Information]
• Watts, C., McLoughlin, K., Goumas, C., Van Kemenade, C., Aitken, J., Soyer, H., Fernandez Penas, P., Guitera, P., Scolyer, R., Morton, R., Menzies, S., Caruana, M., Kang, Y., Mann, G., Madronio, C., Armstrong, B., Thompson, J., Cust, A., et al (2021). Association between Melanoma Detected during Routine Skin Checks and Mortality. JAMA Dermatology, 157(12), 1425-1436. [More Information]
• Davari, D., Orlow, I., Kanetsky, P., Luo, L., Busam, K., Sharma, A., Kricker, A., Cust, A., Anton-Culver, H., Gruber, S., et al (2021). Association of melanoma-risk variants with primary melanoma tumor prognostic characteristics and melanoma-specific survival in the gem study. Current Oncology, 28(6), 4756-4771. [More Information]
• Lacson, J., Zamani, S., Froes, L., Mitra, N., Qian, L., Doyle, S., Azizi, E., Balestrini, C., Bishop, D., Bruno, W., Cust, A., Holland, E., Mann, G., et al (2021). Birth cohort-specific trends of sun-related behaviors among individuals from an international consortium of melanoma-prone families. BMC Public Health, 21(1), 692. [More Information]
• Ackermann, D., Smit, A., Janda, M., Van Kemenade, C., Dieng, M., Morton, R., Turner, R., Cust, A., Irwig, L., Hersch, J., Guitera, P., Saw, R., Drabarek, D., Espinoza, D., Thompson, J., Scolyer, R., Bell, K., et al (2021). Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial. Trials, 22(1), 324. [More Information]
• Liew, A., Cust, A. (2021). Changes in sun protection behaviours, sun exposure and shade availability among adults, children and adolescents in New South Wales, 2003–2016. Australian and New Zealand Journal of Public Health, 45(5), 462-468. [More Information]
• Yardman-Frank, J., Bronner, B., Rosso, S., From, L., Busam, K., Groben, P., Tucker, P., Armstrong, B., Cust, A., Kricker, A., et al (2021). Comparison of community pathologists with expert dermatopathologists evaluating Breslow thickness and histopathologic subtype in a large international population-based study of melanoma. JAAD International, 4, 25-27. [More Information]
• Nguyen, J., Ting, S., Paul, E., Smith, A., Watts, C., Kelly, J., Cust, A., Mar, V. (2021). Diagnostic tools used for melanoma: A survey of Australian general practitioners and dermatologists. Australasian Journal of Dermatology, 62(3), 300-309. [More Information]
• Yardman-Frank, J., Glassheim, E., Kricker, A., Armstrong, B., Marrett, L., Luo, L., Cust, A., Busam, K., Orlow, I., Gallagher, R., et al (2021). Differences in Melanoma Between Canada and New South Wales, Australia: A Population-Based Genes, Environment, and Melanoma (GEM) Study. JID Innovations, 1(1), 100002. [More Information]
• Davari, D., Orlow, I., Kanetsky, P., Luo, L., Edmiston, S., Conway, K., Parrish, E., Hao, H., Busam, K., Sharma, A., Kricker, A., Cust, A., et al (2021). Disease-Associated Risk Variants in ANRIL Are Associated with Tumor-Infiltrating Lymphocyte Presence in Primary Melanomas in the Population-Based GEM Study. Cancer Epidemiology Biomarkers and Prevention, 30(12), 2309-2316. [More Information]
• Guitera, P., Menzies, S., Coates, E., Azzi, A., Fernandez Penas, P., Lilleyman, A., Badcock, C., Schmid, H., Watts, C., Collgros Totosaus, H., Liu, R., Mann, G., Cust, A., et al (2021). Efficiency of Detecting New Primary Melanoma among Individuals Treated in a High-risk Clinic for Skin Surveillance. JAMA Dermatology, 157(5), 521-530. [More Information]
• Holland, E., Lo, S., Kelly, B., Schmid, H., Cust, A., Palmer, J., Drummond, M., Hayward, N., Pritchard, A., Mann, G. (2021). FRAMe: Familial Risk Assessment of Melanoma—a risk prediction tool to guide CDKN2A germline mutation testing in Australian familial melanoma. Familial Cancer, 20(3), 231-239. [More Information]
• Bakshi, A., Yan, M., Riaz, M., Polekhina, G., Orchard, S., Tiller, J., Wolfe, R., Joshi, A., Cao, Y., McInerney-Leo, A., Cust, A., et al (2021). Genomic Risk Score for Melanoma in a Prospective Study of Older Individuals. Journal of the National Cancer Institute, 113(10), 1379-1385. [More Information]
• So, C., Cust, A., Gordon, L., Morton, R., Canfell, K., Ngo, P., Dieng, M., McLoughlin, K., Watts, C. (2021). Health utilities for non‐melanoma skin cancers and pre‐ cancerous lesions: A systematic review. Skin Health and Disease, 1(3), e51. [More Information]
• Kan, J., Dieng, M., Butow, P., Mireskandari, S., Tesson, S., Menzies, S., Costa, D., Morton, R., Mann, G., Cust, A., et al (2021). Identifying the ‘Active Ingredients' of an Effective Psychological Intervention to Reduce Fear of Cancer Recurrence: A Process Evaluation. Frontiers in Psychology, 12. [More Information]
• Smit, A., Allen, M., Beswick, B., Butow, P., Dawkins, H., Dobbinson, S., Dunlop, K., Espinoza, D., Fenton, G., Kanetsky, P., Kirk, J., Lo, S., Mann, G., Reyes Marcelino, G., Morton, R., Newson, A., Trevena, L., Cust, A., et al (2021). Impact of personal genomic risk information on melanoma prevention behaviors and psychological outcomes: a randomized controlled trial. Genetics in Medicine, 23(12), 2394-2403. [More Information]
• Smith, A., Watts, C., Robinson, S., Schmid, H., Goumas, C., Mar, V., Thompson, J., Rapport, F., Cust, A. (2021). Knowledge and attitudes of Australian dermatologists towards sentinel lymph node biopsy for melanoma: a mixed methods study. Australasian Journal of Dermatology, 62(2), 168-176. [More Information]
• Smit, A., Sharman, A., Espinoza, D., Wallingford, C., Young, M., Dunlop, K., Tiller, J., Newson, A., Meiser, B., Cust, A., et al (2021). Knowledge, views and expectations for cancer polygenic risk testing in clinical practice: A cross-sectional survey of health professionals. Clinical Genetics, 100(4), 430-439. [More Information]
• Cho, K., Cust, A., Foo, Y., Eslick, G. (2021). Melanomas and stress patterns on the foot: A systematic review and meta-analysis. Journal Of The American Academy Of Dermatology, 85(1), 256-258. [More Information]
• Bell, K., Loy, C., Cust, A., Teixeira-Pinto, A. (2021). Mendelian Randomization in Cardiovascular Research: Establishing Causality When There Are Unmeasured Confounders. Circulation: Cardiovascular Quality and Outcomes, 14(1), e005623. [More Information]
• Cho, K., Cust, A., Foo, Y., Long, G., Menzies, A., Eslick, G. (2021). Metastatic acral melanoma treatment outcomes: a systematic review and meta-analysis. Melanoma Research, 31(5), 482-486. [More Information]
• Reyes Marcelino, G., Tabbakh, T., Espinoza, D., Sinclair, C., Kang, Y., McLoughlin, K., Caruana, M., Fernandez Penas, P., Guitera, P., Aitken, J., Canfell, K., Cust, A., et al (2021). Prevalence of skin examination behaviours among Australians over time. Cancer Epidemiology, 70, 101874. [More Information]
• Laskar, R., Ferreiro-Iglesias, A., Bishop, D., Iles, M., Kanetsky, P., Armstrong, B., Law, M., Goldstein, A., Aitken, J., Giles, G., Cust, A., et al (2021). Risk factors for melanoma by anatomical site: an evaluation of aetiological heterogeneity*. British Journal of Dermatology, 184(6), 1085-1093. [More Information]
• Reyes Marcelino, G., Wang, R., Gultekin, S., Humphreys, L., Smit, A., Sharman, A., St Laurent, A., Evaquarta, R., Dobbinson, S., Cust, A. (2021). School-based interventions to improve sun-safe knowledge, attitudes and behaviors in childhood and adolescence: A systematic review. Preventive Medicine, 146, 1-11. [More Information]
• El Sharouni, M., Stodell, M., Ahmed, T., Suijkerbuijk, K., Cust, A., Witkamp, A., Sigurdsson, V., van Diest, P., Scolyer, R., Thompson, J., Lo, S., et al (2021). Sentinel node biopsy in patients with melanoma improves the accuracy of staging when added to clinicopathological features of the primary tumor. Annals of Oncology, 32(3), 375-383. [More Information]
• Cust, A. (2021). Strengthening melanoma prevention and early detection among people with type 2 diabetes. British Journal of Dermatology, 185(4), 692-693. [More Information]
• Ribero, S., Cust, A. (2021). Surveillance of patients with thin melanoma. Australasian Journal of Dermatology, 62(4), 530-532. [More Information]

2020

• Cust, A., Badcock, C., Smith, J., Thomas, N., Haydu, L., Armstrong, B., Law, M., Thompson, J., Kanetsky, P., Begg, C., Kricker, A., Lo, S., et al (2020). A risk prediction model for the development of subsequent primary melanoma in a population-based cohort. British Journal of Dermatology, 182(5), 1148-1157. [More Information]
• Ward, S., Gibbs, D., Orlow, I., Thomas, N., Kanetsky, P., Luo, L., Cust, A., Anton-Culver, H., Gruber, S., Gallagher, R., et al (2020). Association of IRF4 single-nucleotide polymorphism rs12203592 with melanoma-specific survival. British Journal of Dermatology, 183(1), 163-165. [More Information]
• Wood, R., Heyworth, J., McCarthy, N., Mauguen, A., Berwick, M., Thomas, N., Millward, M., Anton-Culver, H., Cust, A., Dwyer, T., et al (2020). Association of known melanoma risk factors with primary melanoma of the scalp and neck. Cancer Epidemiology Biomarkers and Prevention, 29(11), 2203-2210. [More Information]
• Watts, C., Smith, A., Robinson, S., Chang, C., Goumas, C., Schmid, H., Kelly, J., Hong, A., Scolyer, R., Long, G., Spillane, A., Morton, R., Saw, R., Varey, A., Mann, G., Thompson, J., Cust, A., et al (2020). Australian general practitioners' attitudes and knowledge of sentinel lymph node biopsy in melanoma management. Australian Journal of General Practice, 49(6), 355-362. [More Information]
• Dieng, M., Morton, R., Costa, D., Butow, P., Menzies, S., Lo, S., Mann, G., Cust, A., Kasparian, N. (2020). Benefits of a brief psychological intervention targeting fear of cancer recurrence in people at high risk of developing another melanoma: 12-month follow-up results of a randomized controlled trial. Asia-Pacific Journal of Clinical Oncology, 182(4), 860-868. [More Information]
• Vuong, K., Armstrong, B., Drummond, M., Hopper, J., Barrett, J., Davies, J., Bishop, D., Newton-Bishop, J., Aitken, J., Giles, G., Schmid, H., Mann, G., McGeechan, K., Cust, A., et al (2020). Development and external validation study of a melanoma risk prediction model incorporating clinically assessed naevi and solar lentigines. British Journal of Dermatology, 182(5), 1262-1268. [More Information]
• Janda, M., Cust, A., Neale, R., Aitken, J., Baade, P., Green, A., Khosrotehrani, K., Mar, V., Soyer, H., Whiteman, D. (2020). Early detection of melanoma: a consensus report from the Australian Skin and Skin Cancer Research Centre Melanoma Screening Summit. Australian and New Zealand Journal of Public Health, 44(2), 111-115. [More Information]
• Cust, A. (2020). Gene–environment interactions and melanoma risk. British Journal of Dermatology, 183(2), 205-206. [More Information]
• Landi, M., Bishop, D., MacGregor, S., Machiela, M., Stratigos, A., Ghiorzo, P., Brossard, M., Calista, D., Choi, J., Fargnoli, M., Scolyer, R., Mann, G., Cust, A., Long, G., et al (2020). Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility. Nature Genetics, 52(5), 494-504. [More Information]
• Mangantig, E., MacGregor, S., Iles, M., Scolyer, R., Cust, A., Hayward, N., Montgomery, G., Duffy, D., Thompson, J., Henders, A., Mann, G., Long, G., et al (2020). Germline variants are associated with increased primary melanoma tumor thickness at diagnosis. Human Molecular Genetics, 29(21), 3578-3587. [More Information]
• Smith, A., Watts, C., Robinson, S., Schmid, H., Chang, C., Thompson, J., Rapport, F., Cust, A. (2020). GPs' involvement in diagnosing, treating, and referring patients with suspected or confirmed primary cutaneous melanoma: A qualitative study. BJGP Open, 4(2), 1028. [More Information]
• Rapport, F., Smith, A., Cust, A., Mann, G., Watts, C., Gyorki, D., Henderson, M., Hong, A., Kelly, J., Long, G., Morton, R., Saw, R., Scolyer, R., Spillane, A., Thompson, J., et al (2020). Identifying challenges to implementation of clinical practice guidelines for sentinel lymph node biopsy in patients with melanoma in Australia: Protocol paper for a mixed methods study. BMJ Open, 10(2), e032636. [More Information]
• Smit, A., Keogh, L., Reyes Marcelino, G., Dunlop, K., Newson, A., Cust, A. (2020). Implementation considerations for offering personal genomic risk information to the public: A qualitative study. BMC Public Health, 20(1), 1028. [More Information]
• Gibbs, D., Orlow, I., Vernali, S., Powell, H., Kanetsky, P., Luo, L., Busam, K., Sharma, A., Kricker, A., Armstrong, B., Cust, A., et al (2020). Inherited Melanoma Risk Variants Associated with Histopathologically Amelanotic Melanoma. Journal of Investigative Dermatology, 140(4), 918-922.e7. [More Information]
• Baade, P., Whiteman, D., Janda, M., Cust, A., Neale, R., Smithers, B., Green, A., Khosrotehrani, K., Mar, V., Soyer, H., et al (2020). Long-term deaths from melanoma according to tumor thickness at diagnosis. International Journal of Cancer, 147(5), 1391-1396. [More Information]
• Law, M., Aoude, L., Duffy, D., Long, G., Johansson, P., Pritchard, A., Khosrotehrani, K., Mann, G., Montgomery, G., Iles, M., Cust, A., Shannon, K., Spillane, A., Stretch, J., Thompson, J., Saw, R., Scolyer, R., et al (2020). Multiplex melanoma families are enriched for polygenic risk. Human Molecular Genetics, 29(17), 2976-2985. [More Information]
• Lo, S., Smit, A., Espinoza, D., Cust, A. (2020). The Melanoma Genomics Managing Your Risk Study randomised controlled trial: statistical analysis plan. Trials, 21(1), 594. [More Information]
• Cust, A. (2020). Who dies from thin melanoma? British Journal of Dermatology, 182(4), 827-828. [More Information]

2019

• Cust, A., Drummond, M., Bishop, D., Azizi, L., Schmid, H., Jenkins, M., Hopper, J., Armstrong, B., Aitken, J., Kefford, R., Mann, G., et al (2019). Associations of pigmentary and naevus phenotype with melanoma risk in two populations with comparable ancestry but contrasting levels of ambient sun exposure. Journal of the European Academy of Dermatology and Venereology, 33(10), 1874-1885. [More Information]
• Weber, M., Marshall, H., Rankin, N., Duffy, S., Fong, K., Dunlop, K., Humphreys, L., Smit, A., Cust, A., Taylor, N., Kang, Y., Armstrong, B., et al (2019). Cancer screening in Australia: future directions in melanoma, Lynch syndrome, and liver, lung and prostate cancers. Public Health Research and Practice, 29(2), 1-9. [More Information]
• Dieng, M., Khanna, N., Kasparian, N., Costa, D., Butow, P., Menzies, S., Mann, G., Cust, A., Morton, R. (2019). Cost-Effectiveness of a Psycho-Educational Intervention Targeting Fear of Cancer Recurrence in People Treated for Early-Stage Melanoma. Applied Health Economics and Health Policy, 17(5), 669-681. [More Information]
• Taylor, N., Mitra, N., Qian, L., Avril, M., Bishop, D., Bressac-de Paillerets, B., Bruno, W., Calista, D., Cuellar, F., Cust, A., Holland, E., Mann, G., Schmid, H., et al (2019). Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT. Journal Of The American Academy Of Dermatology, 81(2), 386-394. [More Information]
• Fenton, G., Smit, A., Keogh, L., Cust, A. (2019). Exploring the emotional and behavioural reactions to receiving personalized melanoma genomic risk information: a qualitative study. British Journal of Dermatology, 180(6), 1390-1396. [More Information]
• Aldrich, M., Cust, A., Raynes-Greenow, C. (2019). Gender equity in epidemiology: a policy brief. Annals of Epidemiology, 35, 1-3. [More Information]
• Smit, A., Newson, A., Keogh, L., Best, M., Dunlop, K., Vuong, K., Kirk, J., Butow, P., Trevena, L., Cust, A. (2019). GP attitudes to and expectations for providing personal genomic risk information to the public: a qualitative study. BJGP Open, 3(1), 1-10. [More Information]
• Cust, A., Pellegrini, C., Botta, F., Massi, D., Martorelli, C., Facchetti, F., Gandini, S., Maisonneuve, P., Avril, M., Demenais, F., et al (2019). MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort. The Lancet Child and Adolescent Health, 3(5), 332-342. [More Information]
• Dieng, M., Smit, A., Hersch, J., Morton, R., Cust, A., Irwig, L., Low, D., Low, C., Bell, K. (2019). Patients' Views About Skin Self-examination After Treatment for Localized Melanoma. JAMA Dermatology, 155(8), 914-921. [More Information]
• Miles, J., Orlow, I., Kanetsky, P., Luo, L., Cust, A., Armstrong, B., Kricker, A., Anton-Culver, H., Gruber, S., Gallagher, R., et al (2019). Relationship of Chromosome Arm 10q Variants to Occurrence of Multiple Primary Melanoma in the Population-Based GEM Study. Journal of Investigative Dermatology, 139(6), 1410-1412. [More Information]
• Morton, R., Asher, R., Peyton, E., Tran, A., Smit, A., Butow, P., Kimlin, M., Dobbinson, S., Wordsworth, S., Keogh, L., Cust, A. (2019). Risk attitudes and sun protection behaviour: Can behaviour be altered by using a melanoma genomic risk intervention? Cancer Epidemiology, 61, 8-13. [More Information]
• Guitera, P., Collgros, H., Madronio, C., Goumas, C., Mann, G., Watts, C., Pereira, A., Armstrong, B., Drummond, M., Morton, R., Scolyer, R., Menzies, S., Thompson, J., Cust, A. (2019). The steadily growing problem of lentigo maligna and lentigo maligna melanoma in Australia: Population-based data on diagnosis and management. Australasian Journal of Dermatology, 60(2), 118-125. [More Information]

2018

• Watts, C., Wortley, S., Norris, S., Menzies, S., Guitera, P., Askie, L., Mann, G., Morton, R., Cust, A. (2018). A National Budget Impact Analysis of a Specialised Surveillance Programme for Individuals at Very High Risk of Melanoma in Australia. Applied Health Economics and Health Policy, 16(2), 235-242. [More Information]
• Cust, A., Drummond, M., Kanetsky, P., Goldstein, A., Barrett, J., MacGregor, S., Law, M., Iles, M., Bui, M., Hopper, J., Mann, G., et al (2018). Assessing the incremental contribution of common genomic variants to melanoma risk prediction in two population-based studies. Journal of Investigative Dermatology, 138(12), 2617-2624. [More Information]
• Bell, K., Cust, A. (2018). Beyond country-specific incidence and mortality: the global burden of melanoma. British Journal of Dermatology, 178(2), 315-316. [More Information]
• Cormie, P., Atkinson, M., Bucci, L., Cust, A., Eakin, E., Hayes, S., McCarthy, S., Murnane, A., Patchell, S., Adams, D. (2018). Clinical Oncology Society of Australia position statement on exercise in cancer care. Medical Journal of Australia, 209(4), 184-187. [More Information]
• Gu, F., Chen, T., Pfeiffer, R., Fargnoli, M., Calista, D., Ghiorzo, P., Peris, K., Puig, S., Menin, C., Cust, A., et al (2018). Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma. Human Molecular Genetics, 27(23), 4145-4156. [More Information]
• Fenton, G., Smit, A., Freeman, L., Badcock, C., Dunlop, K., Butow, P., Kirk, J., Cust, A. (2018). Development and Evaluation of a Telephone Communication Protocol for the Delivery of Personalized Melanoma Genomic Risk to the General Population. Journal of Genetic Counseling, 27(2), 370-380. [More Information]
• Smit, A., Newson, A., Best, M., Badcock, C., Butow, P., Kirk, J., Dunlop, K., Fenton, G., Cust, A. (2018). Distress, uncertainty, and positive experiences associated with receiving information on personal genomic risk of melanoma. European Journal of Human Genetics, 26, 1094-1100. [More Information]
• Cormie, P., Adams, D., Atkinson, M., Bucci, L., Cust, A., Eakin, E., McCarthy, A., Murnane, A., Quinn, S., Hayes, S. (2018). Exercise as part of routine cancer care. The Lancet Oncology, 19(9), e432-e432. [More Information]
• Read, R., Madronio, C., Cust, A., Goumas, C., Watts, C., Menzies, S., Curtin, A., Mann, G., Thompson, J., Morton, R. (2018). Follow-Up Recommendations after Diagnosis of Primary Cutaneous Melanoma: A Population-Based Study in New South Wales, Australia. Annals of Surgical Oncology, 25(3), 617-625. [More Information]
• Thomas, N., Edmiston, S., Orlow, I., Kanetsky, P., Luo, L., Gibbs, D., Parrish, E., Hao, H., Busam, K., Armstrong, B., Cust, A., Kricker, A., et al (2018). Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes. Journal of Investigative Dermatology, 138(11), 2398-2404. [More Information]
• Cust, A., Mishra, K., Berwick, M. (2018). Melanoma-role of the environment and genetics. Photochemical & Photobiological Sciences, 17(12), 1853-1860. [More Information]
• Duffy, D., Zhu, G., Li, X., Sanna, M., Iles, M., Jacobs, L., Evans, D., Yazar, S., Beesley, J., Law, M., Mann, G., Cust, A., et al (2018). Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways. Nature Communications, 9(1), 1-10. [More Information]
• Vuong, K., Armstrong, B., McGeechan, K., Cust, A. (2018). Personalized melanoma risk assessments and tailored prevention advice: A pragmatic randomized controlled trial in Australian general practice. Family Practice, 36(2), 237-246. [More Information]
• Liyanage, U., Law, M., Ong, J., Cust, A., Mann, G., Ward, S., Gharahkhani, P., Iles, M., MacGregor, S. (2018). Polyunsaturated fatty acids and risk of melanoma: A Mendelian randomisation analysis. International Journal of Cancer, 143(3), 508-514. [More Information]
• Cust, A. (2018). Prognostic features for acral lentiginous melanoma. British Journal of Dermatology, 178(2), 311-312. [More Information]
• Dieng, M., Kasparian, N., Cust, A., Costa, D., Tran, A., Butow, P., Menzies, S., Mann, G., Morton, R. (2018). Sensitivity of Preference-Based Quality-of-Life Measures for Economic Evaluations in Early-Stage Melanoma. JAMA Dermatology, 154(1), 52-59. [More Information]
• Watts, C., Drummond, M., Goumas, C., Schmid, H., Armstrong, B., Aitken, J., Jenkins, M., Giles, G., Hopper, J., Mann, G., Cust, A. (2018). Sunscreen use and melanoma risk among young Australian adults. JAMA Dermatology, 154(9), 1001-1009. [More Information]
• Bell, K., Cust, A., Scolyer, R. (2018). The importance of population-based estimates of melanocytic pathology. JAMA Dermatology, 154(1), 15-17. [More Information]
• Orlow, I., Shi, Y., Kanetsky, P., Thomas, N., Luo, L., Corrales-Guerrero, S., Cust, A., Sacchetto, L., Zanetti, R., Rosso, S., et al (2018). The interaction between Vitamin D Receptor polymorphisms and sun exposure around time of diagnosis influences melanoma survival. Pigment Cell & Melanoma Research, 31(2), 287-296. [More Information]
• Smit, A., Newson, A., Morton, R., Kimlin, M., Keogh, L., Law, M., Kirk, J., Dobbinson, S., Kanetsky, P., Fenton, G., Butow, P., Trevena, L., Lo, S., Savard, J., Mann, G., Cust, A., et al (2018). The melanoma genomics managing your risk study: A protocol for a randomized controlled trial evaluating the impact of personal genomic risk information on skin cancer prevention behaviors. Contemporary Clinical Trials, 70, 106-116. [More Information]
• Cust, A., Fenton, G., Smit, A., Espinoza, D., Dobbinson, S., Brodie, A., Dang, H., Kimlin, M. (2018). Validation of Questionnaire and Diary Measures of Time Outdoors Against an Objective Measure of Personal Ultraviolet Radiation Exposure. Photochemistry and Photobiology, 94(4), 815-820. [More Information]
• Cust, A., Aitken, J., Baade, P., Whiteman, D., Soyer, H., Janda, M. (2018). Why a randomised melanoma screening trial may be a good idea. British Journal of Dermatology, 179(5), 1227-1232. [More Information]

2017

• Smit, A., Espinoza, D., Newson, A., Morton, R., Fenton, G., Freeman, L., Dunlop, K., Butow, P., Law, M., Kimlin, M., Kirk, J., Mann, G., Cust, A., et al (2017). A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public. Cancer Epidemiology Biomarkers and Prevention, 26(2), 212-221. [More Information]
• Vernali, S., Waxweiler, W., Dillon, P., Kanetsky, P., Orlow, I., Luo, L., Busam, K., Kricker, A., Armstrong, B., Anton-Culver, H., Cust, A., et al (2017). Association of incident amelanotic melanoma with phenotypic characteristics, MC1R status, and prior amelanotic melanoma. JAMA Dermatology, 153(10), 1026-1031. [More Information]
• Thomas, N., Edmiston, S., Kanetsky, P., Busam, K., Kricker, A., Armstrong, B., Cust, A., Anton-Culver, H., Gruber, S., Luo, L., et al (2017). Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in Melanoma. Journal of Investigative Dermatology, 137(12), 2588-2598. [More Information]
• Watts, C., Madronio, C., Morton, R., Goumas, C., Armstrong, B., Curtin, A., Menzies, S., Mann, G., Thompson, J., Cust, A. (2017). Clinical Features Associated With Individuals at Higher Risk of Melanoma: A Population-Based Study. JAMA Dermatology, 153(1), 23-29. [More Information]
• Watts, C., Cust, A., Menzies, S., Mann, G., Morton, R. (2017). Cost-effectiveness of skin surveillance through a specialized clinic for patients at high risk of Melanoma. Journal of Clinical Oncology, 35(1), 63-71. [More Information]
• Watts, C., Madronio, C., Morton, R., Goumas, C., Armstrong, B., Curtin, A., Menzies, S., Mann, G., Thompson, J., Cust, A. (2017). Diagnosis and clinical management of melanoma patients at higher risk of a new primary melanoma: A population-based study in New South Wales, Australia. Australasian Journal of Dermatology, 58(4), 278-285. [More Information]
• Smit, A., Keogh, L., Newson, A., Butow, P., Dunlop, K., Morton, R., Kirk, J., Espinoza, D., Cust, A. (2017). Does personalized melanoma genomic risk information trigger conversations about skin cancer prevention and skin examination with family, friends and health professionals? British Journal of Dermatology, 177(3), 779-790. [More Information]
• Cust, A. (2017). Estimating the future health service burden of keratinocyte cancers in the UK. British Journal of Dermatology, 176(5), 1107-1108. [More Information]
• Fang, J., Jia, J., Makowski, M., Xu, M., Wang, Z., Zhang, T., Hoskins, J., Choi, J., Han, Y., Zhang, M., et al (2017). Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148. Nature Communications, 8, 1-15. [More Information]
• Gibbs, D., Ward, S., Orlow, I., Cadby, G., Kanetsky, P., Luo, L., Busam, K., Kricker, A., Armstrong, B., Cust, A., et al (2017). Functional melanoma-risk variant IRF4 rs12203592 associated with Breslow thickness: a pooled international study of primary melanomas. British Journal of Dermatology, 177(5), e180-e182. [More Information]
• Taylor, N., Mitra, N., Goldstein, A., Tucker, M., Avril, M., Azizi, E., Bergman, W., Bishop, D., Bressac-de Paillerets, B., Cust, A., Mann, G., et al (2017). Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families. Journal of Investigative Dermatology, 137(12), 2606-2612. [More Information]
• Cust, A., Murrell, D. (2017). Increasing prevalence but not incidence of psoriasis in the U.K. British Journal of Dermatology, 176(3), 568-569. [More Information]
• Varey, A., Madronio, C., Cust, A., Goumas, C., Mann, G., Armstrong, B., Scolyer, R., Curtin, A., Thompson, J. (2017). Poor Adherence to National Clinical Management Guidelines: A Population-Based, Cross-Sectional Study of the Surgical Management of Melanoma in New South Wales, Australia. Annals of Surgical Oncology, 24(8), 2080-2088. [More Information]
• Dieng, M., Kasparian, N., Mireskandari, S., Butow, P., Costa, D., Morton, R., Mann, G., Menzies, S., Cust, A. (2017). Psychoeducational intervention for people at high risk of developing another melanoma: a pilot randomised controlled trial. BMJ Open, 7(e015195), 1-9. [More Information]
• Trevena, L., Shepherd, H., Bonner, C., Jansen, J., Cust, A., Leask, J., Shadbolt, N., Del Mar, C., McCaffery, K., Hoffmann, T. (2017). Shared decision making in Australia in 2017 [Partizipative Entscheidungsfindung in Australien im Jahr 2017]. German Journal for Evidence and Quality in Health Care (Zeitschrift fur Evidenz, Fortbildung und Qualitaet im Gesundheitswesen), 123-124, 17-20. [More Information]
• Armstrong, B., Cust, A. (2017). Sun exposure and skin cancer, and the puzzle of cutaneous melanoma: A perspective on Fears et al. Mathematical models of age and ultraviolet effects on the incidence of skin cancer among whites in the United States American Journal of Epidemiology 1977; 105: 420-427. Cancer Epidemiology, 48, 147-156. [More Information]

2016

• Kasparian, N., Mireskandari, S., Butow, P., Dieng, M., Cust, A., Meiser, B., Barlow-Stewart, K., Menzies, S., Mann, G. (2016). "Melanoma: Questions and Answers." Development and evaluation of a psycho-educational resource for people with a history of melanoma. Supportive Care in Cancer, 24(12), 4849-4859. [More Information]
• Gibbs, D., Orlow, I., Bramson, J., Kanetsky, P., Luo, L., Kricker, A., Armstrong, B., Anton-Culver, H., Gruber, S., Marrett, L., Cust, A., et al (2016). Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways. Journal of the National Cancer Institute, 108(7), 1-9. [More Information]
• Vuong, K., Armstrong, B., Weiderpass, E., Lund, E., Adami, H., Veierod, M., Barrett, J., Davies, J., Bishop, T., Whiteman, D., Mann, G., Cust, A., McGeechan, K., et al (2016). Development and external validation of a melanoma risk prediction model based on self-assessed risk factors. JAMA Dermatology, 152(8), 889-896. [More Information]
• Madronio, C., Armstrong, B., Watts, C., Goumas, C., Morton, R., Curtin, A., Menzies, S., Mann, G., Thompson, J., Cust, A. (2016). Doctors' recognition and management of melanoma patients' risk: An Australian population-based study. Cancer Epidemiology, 45, 32-39. [More Information]
• Dieng, M., Cust, A., Kasparian, N., Mann, G., Morton, R. (2016). Economic evaluations of psychosocial interventions in cancer: a systematic review. Psycho-Oncology, 25(12), 1380-1392. [More Information]
• Berwick, M., Buller, D., Cust, A., Gallagher, R., Lee, T., Meyskens, F., Pandey, S., Thomas, N., Veierod, M., Ward, S. (2016). Melanoma Epidemiology and Prevention. In Howard L. Kaufman and Janice M. Mehnert (Eds.), Melanoma: Cancer Treatment and Research, (pp. 17-49). Cham: Springer. [More Information]
• Taylor, N., Thomas, N., Anton-Culver, H., Armstrong, B., Begg, C., Busam, K., Cust, A., Dwyer, T., From, L., Gallagher, R., et al (2016). Nevus count associations with pigmentary phenotype, histopathological melanoma characteristics and survival from melanoma. International Journal of Cancer, 139(6), 1217-1222. [More Information]
• Taylor, N., Handorf, E., Mitra, N., Avril, M., Azizi, E., Bergman, W., Bianchi-Scarra, G., Bishop, D., Bressac-de Paillerets, B., Cust, A., Holland, E., Mann, G., Olsson, H., Schmid, H., et al (2016). Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma Families. Journal of Investigative Dermatology, 136(5), 166-169. [More Information]
• Farrokhzadi, L., Dhillon, H., Goumas, C., Young, J., Cust, A. (2016). Physical Activity Correlates, Barriers, and Preferences for Women With Gynecological Cancer. International Journal of Gynecological Cancer, 26(8), 1530-1537. [More Information]
• Dieng, M., Cust, A., Kasparian, N., Butow, P., Costa, D., Menzies, S., Mann, G., Morton, R. (2016). Protocol for a within-trial economic evaluation of a psychoeducational intervention tailored to people at high risk of developing a second or subsequent melanoma. BMJ Open, 6(10), 1-8. [More Information]
• Dieng, M., Butow, P., Costa, D., Morton, R., Menzies, S., Mireskandari, S., Tesson, S., Mann, G., Cust, A., Kasparian, N. (2016). Psychoeducational intervention to reduce fear of cancer recurrence in people at high risk of developing another primary melanoma: results of a randomized controlled trial. Journal of Clinical Oncology, 34(36), 4405-4414. [More Information]
• Costa, D., Dieng, M., Cust, A., Butow, P., Kasparian, N. (2016). Psychometric properties of the Fear of Cancer Recurrence Inventory: an item response theory approach. Psycho-Oncology, 25(7), 832-838. [More Information]
• Smit, A., Keogh, L., Hersch, J., Newson, A., Butow, P., Williams, G., Cust, A. (2016). Public preferences for communicating personal genomic risk information: a focus group study. Health Expectations, 19(6), 1203-1214. [More Information]
• White, K., Luo, L., Thompson, T., Torres, S., Hu, C., Thomas, N., Lilyquist, J., Anton-Culver, H., Gruber, S., Cust, A., et al (2016). Variants in autophagy-related genes and clinical characteristics in melanoma: a population-based study. Cancer Medicine, 5(11), 3336-3345. [More Information]

2015

• Cust, A., Pickles, K., Goumas, C., Vu, T., Schmid, H., Nagore, E., Kelly, J., Aitken, J., Giles, G., Hopper, J., Mann, G., et al (2015). Accuracy of self-reported nevus and pigmentation phenotype compared with clinical assessment in a population-based study of young Australian Adults. Cancer Epidemiology Biomarkers and Prevention, 24(4), 736-743. [More Information]
• Thomas, N., Edmiston, S., Alexander, A., Groben, P., Parrish, E., Kricker, A., Armstrong, B., Anton-Culver, H., Gruber, S., Cust, A., et al (2015). Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher Risk Primary Melanoma. JAMA Oncology, 1(3), 359-368. [More Information]
• Watts, C., Dieng, M., Morton, R., Mann, G., Menzies, S., Cust, A. (2015). Clinical practice guidelines for identification, screening and follow-up of individuals at high risk of primary cutaneous melanoma: a systematic review. British Journal of Dermatology, 172(1), 33-47. [More Information]
• Smit, A., Keogh, L., Newson, A., Hersch, J., Butow, P., Cust, A. (2015). Exploring the Potential Emotional and Behavioural Impact of Providing Personalised Genomic Risk Information to the Public: A Focus Group Study. Public Health Genomics, 18(5), 309-317. [More Information]
• Perez, D., Kite, J., Dunlop, S., Cust, A., Goumas, C., Cotter, T., Walsberger, S., Dessaix, A., Bauman, A. (2015). Exposure to the 'Dark Side of Tanning' skin cancer prevention mass media campaign and its association with tanning attitudes in New South Wales, Australia. Health Education Research, 30(2), 336-346. [More Information]
• Law, M., Bishop, D., Lee, J., Brossard, M., Martin, N., Moses, E., Song, F., Barrett, J., Kumar, R., Easton, D., Mann, G., Cust, A., et al (2015). Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma. Nature Genetics, 47(9), 987-995. [More Information]
• Gibbs, D., Orlow, I., Kanetsky, P., Luo, L., Kricker, A., Armstrong, B., Anton-Culver, H., Gruber, S., Marrett, L., Gallagher, R., Cust, A., et al (2015). Inherited Genetic Variants Associated with Occurrence of Multiple Primary Melanoma. Cancer Epidemiology Biomarkers and Prevention, 24(6), 992-997. [More Information]
• Taylor, N., Reiner, A., Begg, C., Cust, A., Busam, K., Anton- Culver, H., Dwyer, T., From, L., Gallagher, R., Gruber, S., et al (2015). Inherited variation at MC1R and ASIP and association with melanoma-specific survival. International Journal of Cancer, 136(11), 2659-2667. [More Information]
• Taylor, N., Busam, K., From, L., Groben, P., Anton-Culver, H., Cust, A., Begg, C., Dwyer, T., Gallagher, R., Gruber, S., et al (2015). Inherited variation at MC1R and histological characteristics of primary melanoma. PloS One, 10(3), 1-10. [More Information]
• Watts, C., Cust, A., Menzies, S., Coates, E., Mann, G., Morton, R. (2015). Specialized surveillance for individuals at high risk for melanoma a cost analysis of a high-risk clinic. JAMA Dermatology, 151(2), 178-186. [More Information]
• Cust, A., Girgis, A., Armstrong, B. (2015). Sun Exposure and Cancer Risk. In J C Holland, W S Breitbart, P N Butow, P B Jacobsen, M J Loscalzo, R McCorkle (Eds.), Psycho-Oncology: Third edition, (pp. 22-27). New York: Oxford University Press. [More Information]
• Dieng, M., Kasparian, N., Morton, R., Mann, G., Butow, P., Menzies, S., Costa, D., Cust, A. (2015). The Melanoma care study: protocol of a randomised controlled trial of a psycho-educational intervention for melanoma survivors at high risk of developing new primary disease. BMC Psychology, 3(1), 1-13. [More Information]

2014

• Song, F., Amos, C., Lee, J., Lian, C., Fang, S., Liu, H., MacGregor, S., Iles, M., Law, M., Lindeman, N., Cust, A., Kefford, R., Armstrong, B., Mann, G., et al (2014). Identification of a melanoma susceptibility locus and somatic mutation in TET2. Carcinogenesis, 35(9), 2097-2101. [More Information]
• Dieng, M., Watts, C., Kasparian, N., Morton, R., Mann, G., Cust, A. (2014). Improving subjective perception of personal cancer risk: systematic review and meta-analysis of educational interventions for people with cancer or at high risk of cancer. Psycho-Oncology, 23(6), 613-625. [More Information]
• Berwick, M., MacArthur, J., Orlow, I., Kanetsky, P., Begg, C., Luo, L., Reiner, A., Sharma, A., Armstrong, B., Kricker, A., Cust, A., et al (2014). MITF E318K's effect on melanoma risk independent of, but modified by, other risk factors. Pigment Cell & Melanoma Research, 27(3), 485-488. [More Information]
• Lu, Y., Weronica, E., Whiteman, D., Vaughan, T., Spurdle, A., Easton, D., Pharoah, P., Thompson, D., Dunning, A., Hayward, N., Armstrong, B., Cust, A., Holland, E., Kefford, R., Mann, G., Schmid, H., et al (2014). Most common 'sporadic' cancers have a significant germline genetic component. Human Molecular Genetics, 23(22), 6112-6118. [More Information]
• Vuong, K., McGeechan, K., Armstrong, B., Cust, A. (2014). Occupational sun exposure and risk of melanoma according to anatomical site. International Journal of Cancer, 134(11), 2735-2741. [More Information]
• Harland, M., Cust, A., Badenas, C., Chang, Y., Holland, E., Aguilera, P., Aitken, J., Armstrong, B., Barrett, J., Carrera, C., Agha-Hamilton, C., Kefford, R., Kolm, I., Schmid, H., Mann, G., et al (2014). Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia, Spain and the United Kingdom. Hereditary Cancer in Clinical Practice, 12(1), 1-10. [More Information]
• Vuong, K., McGeechan, K., Armstrong, B., Cust, A. (2014). Risk prediction models for incident primary cutaneous melanoma: a systematic review. JAMA Dermatology, 150(4), 434-444. [More Information]
• Berwick, M., Reiner, A., Paine, S., Armstrong, B., Kricker, A., Goumas, C., Cust, A., Thomas, N., Groben, P., From, L., et al (2014). Sun exposure and melanoma survival: a GEM study. Cancer Epidemiology Biomarkers and Prevention, 23(10), 2145-2152. [More Information]
• Iles, M., Bishop, D., Taylor, J., Hayward, N., Brossard, M., Cust, A., Dunning, A., Lee, J., Moses, E., Akslen, L., Mann, G., et al (2014). The Effect on Melanoma Risk of Genes Previously Associated With Telomere Length. Journal of the National Cancer Institute, 106(10), 1-5. [More Information]

2013

• Iles, M., Law, M., Stacey, S., Han, J., Fang, S., Pfeiffer, R., Harland, M., MacGregor, S., Taylor, J., Aben, K., Cust, A., Mann, G., et al (2013). A variant in FTO shows association with melanoma risk not due to BMI. Nature Genetics, 45(4), 428-432. [More Information]
• Liu, H., Wang, L., Liu, Z., Chen, W., Amos, C., Lee, J., Iles, M., Law, M., Barrett, J., Montgomery, G., Cust, A., Mann, G., et al (2013). Association between functional polymorphisms in genes involved in the MAPK signaling pathways and cutaneous melanoma risk. Carcinogenesis, 34(4), 885-892. [More Information]
• Qian, J., Liu, H., Wei, S., Liu, Z., Li, Y., Wang, L., Chen, W., Amos, C., Lee, J., Iles, M., Cust, A., Mann, G., et al (2013). Association between putative functional variants in the PSMB9 gene and risk of melanoma - re-analysis of published melanoma genome-wide association studies. Pigment Cell & Melanoma Research, 26(3), 392-401. [More Information]
• Dossus, L., Lukanova, A., Rinaldi, S., Allen, N., Cust, A., Becker, S., Tjonneland, A., Hansen, L., Overvad, K., Chabbert-Buffet, N., et al (2013). Hormonal, metabolic, and inflammatory profiles and endometrial cancer risk within the EPIC cohort - A factor analysis. American Journal of Epidemiology, 177(8), 787-799. [More Information]
• Cust, A., Goumas, C., Vuong, K., Davies, J., Barrett, J., Holland, E., Schmid, H., Agha-Hamilton, C., Armstrong, B., Kefford, R., Mann, G., et al (2013). MC1R genotype as a predictor of early-onset melanoma, compared with self-reported and physician-measured traditional risk factors: An Australian case-control-family study. BMC Cancer, 13(1), 1-13. [More Information]

2012

• Cust, A., Goumas, C., Holland, E., Agha-Hamilton, C., Aitken, J., Armstrong, B., Giles, G., Kefford, R., Schmid, H., Hopper, J., Mann, G., et al (2012). MC1R genotypes and risk of melanoma before age 40 years: A population-based case-control-family study. International Journal of Cancer, 131(3), E269-2E81. [More Information]

2011

• Yokoyama, S., Woods, S., Boyle, G., Aoude, L., MacGregor, S., Zismann, V., Gartside, M., Cust, A., Haq, R., Harland, M., Holland, E., Schmid, H., Kefford, R., Armstrong, B., Mann, G., et al (2011). A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature, 480(7375), 99-103. [More Information]
• Cust, A., Jenkins, M., Goumas, C., Armstrong, B., Schmid, H., Aitken, J., Giles, G., Kefford, R., Hopper, J., Mann, G. (2011). Early-life sun exposure and risk of melanoma before age 40 years. Cancer Causes and Control, 22(6), 885-897. [More Information]
• MacGregor, S., Montgomery, G., Liu, J., Zhao, Z., Henders, A., Stark, M., Schmid, H., Holland, E., Duffy, D., Zhang, M., Cust, A., Kefford, R., Armstrong, B., Mann, G., et al (2011). Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3. Nature Genetics, 43(11), 1114-1119. [More Information]
• Amos, C., Wang, L., Lee, J., Gershenwald, J., Chen, W., Fang, S., Kosoy, R., Zhang, M., Qureshi, A., Vattathil, S., Mann, G., Cust, A., et al (2011). Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. Human Molecular Genetics, 20(24), 5012-5023. [More Information]
• Barrett, J., Iles, M., Harland, M., Taylor, J., Aitken, J., Andresen, P., Akslen, L., Armstrong, B., Avril, M., Azizi, E., Cust, A., Kefford, R., Mann, G., et al (2011). Genome-wide association study identifies three new melanoma susceptibility loci. Nature Genetics, 43(11), 1108-1113. [More Information]
• Cust, A., Harland, M., Makalic, E., Schmidt, D., Dowty, J., Aitken, J., Agha-Hamilton, C., Armstrong, B., Barrett, J., Chan, M., Holland, E., Kefford, R., Schmid, H., Mann, G., et al (2011). Melanoma risk for CDKN2A mutation carriers who are relatives of population-based case carriers in Australia and the UK. Journal of Medical Genetics, 48(4), 266-272. [More Information]
• Cust, A. (2011). Physical Activity and Gynecologic Cancer Prevention. In Kerry S Courneya and Christine M Friedenreich (Eds.), Physical Activity and Cancer, (pp. 159-185). Germany: Springer Science+Business Media. [More Information]
• Cust, A., Armstrong, B., Goumas, C., Jenkins, M., Schmid, H., Hopper, J., Kefford, R., Giles, G., Aitken, J., Mann, G. (2011). Sunbed Use During Adolescence and Early Adulthood is Associated with Increased Risk of Early-Onset Melanoma. International Journal of Cancer, 128(10), 2425-2435. [More Information]

2010

• Lahmann, P., Cust, A., Friedenreich, C., Schulz, M., Lukanova, A., Kaaks, R., Lundin, E., Tjønneland, A., Halkjaer, J., Tang Severinsen, M., et al (2010). Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition. International Journal of Cancer, 126(10), 2404-2415. [More Information]

2009

• van Bakel, M., Kaaks, R., Feskens, E., Rohrmann, S., Welch, A., Pala, V., Avloniti, K., van der Schouw, Y., van der A, D., Du, H., Cust, A. (2009). Dietary glycaemic index and glycaemic load in the European Prospective Investigation into Cancer and Nutrition. European Journal of Clinical Nutrition, 63(Supplement 4), S188-S205. [More Information]
• van Bakel, M., Slimani, N., Feskens, E., Du, H., Beulens, J., van der Schouw, Y., Brighenti, F., Halkjaer, J., Cust, A., Ferrari, P., Brand-Miller, J., et al (2009). Methodological Challenges in the Application of the Glycemic Index in Epidemiological Studies Using Data from the European Prospective Investigation into Cancer and Nutrition. The Journal of Nutrition, 139(3), 568-575. [More Information]
• Lahmann, P., Friedenreich, C., Schulz, M., Cust, A., Lukanova, A., Kaaks, R., Tjønneland, A., Føns Johnsen, N., Overvad, K., Fournier, A., et al (2009). Physical Activity and Ovarian Cancer Risk: the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiology Biomarkers and Prevention, 18(1), 351-354. [More Information]
• Cust, A., Schmid, H., Maskiell, J., Jetann, J., Ferguson, M., Holland, E., Agha-Hamilton, C., Jenkins, M., Kelly, J., Kefford, R., Armstrong, B., Mann, G., et al (2009). Population-based, Case-Control-Family Design to Investigate Genetic and Environmental Influences on Melanoma Risk: Australian Melanoma Family Study. American Journal of Epidemiology, 170(12), 1541-1554. [More Information]
• Cust, A., Armstrong, B., Smith, B., Chau, J., Van Der Ploeg, H., Bauman, A. (2009). Self-Reported Confidence in Recall as a Predictor of Validity and Repeatability of Physical Activity Questionnaire Data. Epidemiology, 20(3), 433-441. [More Information]
• Cust, A., Stocks, T., Lukanova, A., Lundin, E., Hallmans, G., Kaaks, R., Jonsson, H., Stattin, P. (2009). The influence of overweight and insulin resistance on breast cancer risk and tumour stage at diagnosis: a prospective study. Breast Cancer Research and Treatment, 113(3), 567-576. [More Information]
• Cust, A., Skilton, M., van Bakel, M., Halkjaer, J., Olsen, A., Agnoli, C., Psaltopoulou, T., Buurma, E., Sonestedt, E., Chirlaque, M., et al (2009). Total dietary carbohydrate, sugar, starch and fibre intakes in the European Prospective Investigation into Cancer and Nutrition. European Journal of Clinical Nutrition, 63(Supplement 4), S37-S60. [More Information]

2008

• Allen, N., Key, T., Dossus, L., Rinaldi, S., Cust, A., Lukanova, A., Peeters, P., Onland-Moret, N., Lahmann, P., Berrino, F., et al (2008). Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocrine-Related Cancer, 15(2), 485-497. [More Information]
• Friedenreich, C., Cust, A. (2008). Physical activity and breast cancer risk: impact of timing, type and dose of activity and population subgroup effects. British Journal of Sports Medicine, 42(8), 636-647. [More Information]
• Skilton, M., Laville, M., Cust, A., Moulin, P., Bonnet, F. (2008). The association between dietary macronutrient intake and the prevalence of the metabolic syndrome. British Journal of Nutrition, 100(2), 400-407. [More Information]
• Cust, A., Smith, B., Chau, J., Van Der Ploeg, H., Friedenreich, C., Armstrong, B., Bauman, A. (2008). Validity and repeatability of the EPIC physical activity questionnaire: a validation study using accelerometers as an objective measure. International Journal of Behavioral Nutrition and Physical Activity, 5, 33-1-33-13. [More Information]

2007

• Friedenreich, C., Cust, A., Lahmann, P., Steindorf, K., Boutron–Ruault, M., Clavel-Chapelon, F., Mesrine, S., Linseisen, J., Rohrmann, S., Boeing, H., et al (2007). Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition. Cancer Causes and Control, 18(4), 399-413. [More Information]
• Cust, A., Slimani, N., Kaaks, R., van Bakel, M., Biessy, C., Ferrari, P., Laville, M., Tjønneland, A., Olsen, A., Overvad, K., et al (2007). Dietary Carbohydrates, Glycemic Index, Glycemic Load, and Endometrial Cancer Risk within the European Prospective Investigation into Cancer and Nutrition Cohort. American Journal of Epidemiology, 166(8), 912-923. [More Information]
• Cust, A., Kaaks, R., Friedenreich, C., Bonnet, F., Laville, M., Tjønneland, A., Olsen, A., Overvad, K., Uhre Jakobsen, M., Chajes, V., et al (2007). Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation intoCancer and Nutrition (EPIC). Endocrine-Related Cancer, 14(3), 755-767. [More Information]
• Cust, A., Armstrong, B., Friedenreich, C., Slimani, N., Bauman, A. (2007). Physical activity and endometrial cancer risk: a review of the current evidence, biologic mechanisms and the quality of physical activity assessment methods. Cancer Causes and Control, 18(3), 243-258. [More Information]
• Friedenreich, C., Cust, A., Lahmann, P., Steindorf, K., Boutron–Ruault, M., Clavel-Chapelon, F., Mesrine, S., Linseisen, J., Rohrmann, S., Pischon, T., et al (2007). Physical activity and risk of endometrial cancer: The European prospective investigation into cancer and nutrition. International Journal of Cancer, 121(2), 347-355. [More Information]
• Cust, A., Kaaks, R., Friedenreich, C., Bonnet, F., Laville, M., Lukanova, A., Rinaldi, S., Dossus, L., Slimani, N., Lundin, E., et al (2007). Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women. The Journal of Clinical Endocrinology and Metabolism, 92(1), 255-263. [More Information]
• Al-Zoughool, M., Dossus, L., Kaaks, R., Clavel-Chapelon, F., Tjønneland, A., Olsen, A., Overvad, K., Boutron–Ruault, M., Gauthier, E., Linseisen, J., Cust, A. (2007). Risk of endometrial cancer in relationship to cigarette smoking: Results from the EPIC study. International Journal of Cancer, 121(12), 2741-2747. [More Information]
• Jenab, M., Riboli, E., Cleveland, R., Norat, T., Rinaldi, S., Nieters, A., Biessy, C., Tjønneland, A., Olsen, A., Overvad, K., Cust, A. (2007). Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition. International Journal of Cancer, 121(2), 368-376. [More Information]
• Cust, A., Allen, N., Rinaldi, S., Dossus, L., Friedenreich, C., Olsen, A., Tjønneland, A., Overvad, K., Clavel-Chapelon, F., Boutron–Ruault, M., et al (2007). Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European Prospective Investigation into Cancer and Nutrition. International Journal of Cancer, 120(12), 2656-2664. [More Information]

2006

• Steindorf, K., Friedenreich, C., Linseisen, J., Rohrmann, S., Rundle, A., Veglia, F., Vineis, P., Føns Johnsen, N., Tjønneland, A., Overvad, K., Cust, A. (2006). Physical activity and lung cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort. International Journal of Cancer, 119(10), 2389-2397. [More Information]

2004

• Mohan, P., Tarnow-Mordi, W., Stenson, B., Brokelhurst, P., Haque, K., Cavendish, V., Cust, A. (2004). Can Polyclonal Intravenous Immunoglobulin Limit Cytokine Mediated Cerebral Damage And Chronic Lung Disease In Preterm Infants? Archives of Disease in Childhood: Fetal and Neonatal Edition, 89(1), F5-F8. [More Information]
• Tarnow-Mordi, W., Gebski, V., Cust, A. (2004). Noninvasive Ventilation: To the Editor. New England Journal of Medicine, 351(12), 1257-1257. [More Information]

2003

• Tarnow-Mordi, W., Cust, A., Brocklehurst, P., Gates, S. (2003). Clinical trials for tomorrow funded by the MRC. BMJ: British Medical Journal, Online(13 August 2003).
• Darlow, B., Cust, A., Donoghue, D. (2003). Improved outcomes for very low birthweight infants: evidence from New Zealand national population based data. Archives of Disease in Childhood, 88(1), F23-F28. [More Information]
• Cust, A., Darlow, B., Donoghue, D. (2003). Outcomes for high risk New Zealand newborn infants in 1998-1999: a population based study. Archives of Disease in Childhood, 88(1), F15-F22. [More Information]